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Abstract
Mucosal tissues are critical immune effector sites containing complex populations of leuko-
cytes in a tissue microenvironment that remains incompletely understood. We identify and
quantify in human distal colorectal tissue absolute mucosal CD3+ lymphocytes, including
CD4+ and CD8+ subsets, by direct visualization using immunohistochemistry (IHC), immu-
nofluorescence (IF), and an automated counting protocol (r2=0.90). Sigmoid and rectal mu-
cosal tissues are both densely packed with T lymphocytes in the mucosal compartment.
Both compartments had similar densities of CD3+ T lymphocytes with 37,400 ± 2,801
cells/mm3 and 33,700 ± 4,324 cell/mm3, respectively. Sigmoid mucosa contained 57%
CD3+CD4+ and 40% CD3+CD8+ T lymphocytes which calculates to 21,300 ± 1,476/mm3
and 15,000 ± 275/mm3 T lymphocytes, respectively. Rectal mucosa had 57% CD3+CD4+
and 42% CD3+CD8+ or 21,577 ± 332, and 17,090 ± 1,206 cells/mm3, respectively. By com-
parison, sigmoid mucosal biopsies subjected to conventional collagenase digestion, mono-
nuclear cell (MMC) isolation and staining for flow cytometry yielded 4,549 ± 381/mm3 and
2,708 ± 245/mm3 CD4+ and CD8+ T lymphocytes. These data suggest only ~20.7% recov-
ery compared to IHC results for these markers. Further studies will determine if this reflects
a selective bias in only CD3+, CD4+ and CD8+ T cells or can be generalized to all flow-ana-
lyzed cells from mucosal tissues for phenotyping and functional testing.
Introduction
The mucosal immune compartment is the largest lymphoid reservoir of the body, a critical com-
partment in immune-protection such as in the setting of various infectious diseases and cancer.
Dysfunction can result in certain autoimmune diseases (inflammatory bowel diseases) or
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increased susceptibility to infection. Technical advances have made in situ imaging and quantifi-
cation of labeled cell types feasible, enhancing efforts to characterize immune responses in lym-
phoid organs and peripheral tissues. As direct quantification has been a time-intensive and
variable approach, isolation of mucosal mononuclear cells (MMCs) with subsequent flow cyto-
metric quantification has been the de facto standard to characterize MMC populations of interest.
While long suspected, it has become clear that isolating cells by the disruption of their mi-
croenvironment can profoundly alter their properties [1–2]. Microscopy in situ provides criti-
cal information including accurate tissue localization and spatial relationships of immune cell
populations [3]. Standardizing automated approaches to detect and quantify mucosal-based
cells of interest is critically needed. Given improved automated approaches to quantifying cells
in situ, we sought to investigate the numbers and distributions of mucosal CD3+, CD4+ and
CD8+ T lymphocyte populations in healthy human distal colon and rectum. The numbers of
these cells in tissue have been debated and under-described in the scientific literature [4–7]. To
accomplish this comparative but descriptive study with minimal additional resources, we uti-
lized numbers of mucosal CD3+, CD4+ and CD8+ T lymphocyte populations quantified by
flow cytometry from healthy controls in other NIH-funded studies, leveraging that data to
compare with counts via IHC using newly recruited subjects through the UCLA CFAR’s Muco-
sal Immunology Laboratory Core.
Materials and Methods
Study participants
Data acquired for comparison within this paper was derived from mucosal biopsy samples ac-
quired from two separate NIH-funded, UCLA-based studies: Effects of Aging on GALT
(AG032422; R. Effros, UCLA: PI) (the consent form approves use of samples/data for other
mucosal immune-related, IRB-approved studies) and the UCLA CFAR’s Mucosal Immunology
Laboratory Core (AI2869). This particular study was approved both by the USC and UCLA Of-
fices of the Human Research Protection Program Institutional Review Board and all subjects
provided written informed consent.
Collection of human sigmoid colon and rectal mucosal tissue
Gastrointestinal mucosal biopsies were freshly-acquired from the sigmoid colon and rectum as
previously described [8]. Briefly, healthy HIV-1-seronegative participants without evidence of
rectal sexually transmitted diseases (clinically screened for Chlamydia trachomatis and Neis-
seria gonorrhoeae) or chronic gastrointestinal disorders were recruited to undergo flexible sig-
moidoscopy with biopsies. Using large-cup endoscopic biopsy forceps (Microvasive Radial Jaw
#1589, outside diameter 3.3 mm), biopsies (approximately 1mm deep) were obtained at 5–8
cm from the anal verge (“rectal colon”) and then from 25–30cm (“sigmoid colon”). Whether in
the past (archived data) or present, biopsy specimens were immediately placed in RPMI 1640
and quickly transported to the laboratory, for either preparation for flow cytometry phenotype
characterization (with isolation of mucosal mononuclear cells (MMCs)) or embedded in OCT
medium (Ames Co., Elkhart, IN) and then snap-frozen in liquid nitrogen (~30–45 minutes
from acquisition to freezing). On average, biopsy sizes were ~8mm x 3mm x 1mm.
Section preparation and immunohistochemical tissue staining of T
lymphocytes
Cryostat sections (4 μm thick) were acetone-fixed, blocked with normal horse serum and then
sequentially incubated with the indicated murine anti-human monoclonal antibodies and
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corresponding isotype controls, biotinylated horse anti-mouse IgG, and an avidin/biotin-per-
oxidase. Tissues were counterstained with Vector Hematoxylin QS (Vector Labs; Burlingame,
CA) for light microscopy (Olympus BX51 microscope, Central Valley, PA, equipped with an
Olympus America camera). The following mouse anti-human antibodies were used: anti-CD3
(clone HIT3a; BD Pharmingen, San Diego, CA), anti-CD4 (clone OKT-4; eBioscience, San
Diego, CA), anti-CD8 (clone C8/144B; DAKO, Carpinteria, CA), anti-CD45 (clone 2B11
+PD7/26/16; AbD Serotec, Raleigh, NC), anti-CD1a (clone NA1/34-HLK; AbDSerotec, Ra-
leigh, NC), and CD68 (clone EBM11; DAKO, Carpinteria, CA).
Manual in situ enumeration of tissue T lymphocytes
Immunostained cells in epithelium and lamina propria including lymphoid aggregates were
enumerated as previously described [9]. Slides were scanned using an Aperio ScanScope (Leica
Biosystems, Vista, CA); images were analyzed using Leica’s membrane algorithm in Image-
scope software. On each slide, three separate, non-overlapping regions of interest were circum-
scribed for counting. Each distinct area included 5–10 glands with associated lamina propria
and any lymphoid aggregates. Labeled cells were then counted manually by visualization using
Image Scope imaging software from Leica Technologies, Inc. (Vista, CA) at 40x magnification:
the counts were normalized to cells/mm2 by taking the cell count and dividing by the area of
the region of interest (mm2) then averaging the 3–5 separate regions of interest. The concentra-
tion of cells per cubic mm (mm3) was then calculated by multiplying the cell count/mm2 by
250 (this is derived based on there being approximately 250 slices per biopsy when each sec-
tioned slice is made of 4μm sections in 1mm thickness) and dividing by 3.356 (correction factor
based on the average number of sections in which a T lymphocyte appears in 4μm thick sec-
tions, S1 Fig). For statistical analyses, averages of at least three sections from five biopsies were
utilized (Student t-test).
Automated in situ enumeration of T lymphocytes in colorectal mucosa
Using the same digitally analyzed/recorded areas from the same tissue sections already manu-
ally counted, we used the IHC membrane algorithm from Leica Technologies, Inc. (Vista, CA)
to quantify membrane staining to determine the number of CD3+ mucosal cells/mm3. For
membrane staining, various input parameters were optimized and validated for each tissue
sample and isotype controls. The total number of labeled cells were graded as +1, +2, and +3
(data not shown) for intensity based on three separate areas surrounding similar 5–10 glands
including lamina propria and lymphoid aggregates (when present). The automated-derived
counts were used to calculate cells/mm3 (as above for the manually-counted calculations using
the same sections/areas). For statistical analysis we performed paired t tests on counts obtained
by manual counting and compared them to the counts from the same regions obtained by algo-
rithm analysis. There were no significant differences between counts obtained by manual
counting compared to counts obtained by algorithm. Sigmoid p = 0.552 and rectum p = 0.517.
Two color immunofluorescence of human mucosal tissues
Immunofluorescence was performed by serially incubating cryostat-prepared tissue sections
(1–2 sections away from the above sectioned/enumerated counts; same biopsy samples) with
mouse anti-human monoclonal antibodies against CD3+, CD4+, and CD8+ as above, followed
by incubation with isotype-specific, fluorochrome-labeled, goat anti-mouse antibodies (Alexa
488 and Alexa 568, Molecular Probes, Eugene, OR). Controls included were isotype-matched
control mouse antibodies as well as specific mouse antibodies with a mismatched secondary
antibody. Slides were mounted with ProLong Gold anti-fade reagent with a nuclear marker
T Lymphocytes in Human Colorectal Mucosa
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DAPI (Molecular Probes; Eugene, OR). Images were obtained using confocal laser microscopy
using a Leica-TCS-SP5 MP inverted confocal laser-scanning and two-photon laser microscope
(Heidelberg, Germany) fitted with DPSS-diode (561 nm), argon (488 nm), and two-photon
laser (Spectra-Physics Millenia X 532 diode pump laser and Tsunami picosecond Ti-sapphire
laser) at the Craniofacial Center for Molecular Biology at USC. Sections were illuminated with
488/568 nm for green/red and DAPI for nuclear label. Images of specimens with Alexa 488,
Alexa 568 were recorded sequentially through the spectral emission filters: from 500–550nm
for Alexa 488; 580–700nm for Alexa 568; 410 to 490nm for DAPI). Pairs of single images were
superimposed for co-localization analysis. All micrographs were compiled in serial Z-stack im-
ages 0.1–1.0 μm apart and analyzed and normalized using LAS AF Lite software, Leica Microsys-
tems (Heidelberg, Germany). The number of CD3+/CD4+ and CD3+/CD8+ double positive cells
was assessed in three high-power fields from 3–5 sections of sigmoid and rectal biopsies. The
percentage of double positives was calculated for each section in three areas of 450 x 450 μm2;
the number of double-positive cells/mm3 was determined by taking the percentage of double
positives from the total absolute number of CD3+ cells obtained frommanual counting.
Isolation and flow cytometric analysis of mucosal mononuclear cells
(MMC)
MMCs were isolated from 48 seronegative subjects (30 biopsies per individual) using a previ-
ously optimized protocol [8,10–13]. Briefly, the 30 freshly acquired sigmoid biopsies were
washed once in RPMI 1640 medium and distributed equally to two 50 ml conical centrifuge
tubes (15 biopsies per tube). Samples were incubated in 20–25 ml RPMI/7.5% FCS containing
0.5-mg/ml collagenase type II (Sigma-Aldrich, St. Louis, MO) for 30 minutes in a 37°C water
bath, with intermittent shaking. Tissue fragments were further disrupted by forcing the sus-
pension 5–6 times through a 10 cc disposable syringe attached to a blunt-ended 16-gauge
needle (Stem Cell Technologies, Vancouver, B.C.). The entire suspension was then passed
through a 70 μm sterile plastic strainer (Falcon 2350) to remove free cells while concentrating
the remaining tissue fragments. Free cells were immediately washed twice in RPMI 1640 me-
dium to remove excess collagenase, prior to being resuspended in 500ul–1000ul RPMI with
10% FBS and set aside on ice. Remaining tissue fragments were returned to a 50 ml conical
tube and the entire procedure, including the 30-minute collagenase incubation repeated two
additional times or until tissue fragments were no longer intact. Free cells were combined at
the completion of the digestion and the resultant single cell suspension used for flow
cytometric studies.
Lymphocyte subsets in MMC preparations were quantified by Trucount (BDIS, Mountain
View, CA) according to the manufacturer’s instructions. Briefly, 20μl of Multitest (BDIS,
Mountain View, CA) reagent containing either CD3-FITC/CD8-PE/CD45-peridinin chloro-
phyll protein (PerCP)/CD4-allophycocyanin (APC) or CD3-FITC/CD16+CD56-PE/
CD45-PerCP/CD19-APC was added to two Trucount tubes (contain a known number of fluo-
rescent beads) followed by 100 μl of MMC single cell suspensions. Following incubation for
15 minutes in the dark, any residual red blood cells were lysed and the remaining cells were si-
multaneously fixed by the addition of 450 μl of FACS lysing solution (BDIS, Mountain View,
CA). Samples were analyzed on a FACS Calibur flow cytometer using CellQuest software. A vi-
able lymphocyte gate was established using CD45 and side scatter parameters. T-cells were fur-
ther delineated using a CD3 + gating strategy, with the CD4+/CD8+ subsets determined by
further gating of the well defined populations, as previously described [10]. The absolute num-
bers (cells/μl) of CD45+CD3+CD4+, CD45+CD3+CD8+, CD45+CD3-CD16+CD56+, and
CD45+CD3-CD19+ lymphocytes were then quantified by dividing the number of positive
T Lymphocytes in Human Colorectal Mucosa
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cellular events by the number of bead events and multiplying the result by the bead concentra-
tion. ([Antibody positive cells/Total bead events] x Beads/ul). Absolute numbers per biopsy
were derived from the pooled sample of 30 biopsies.
Results
Similarity to compared study populations
The total study population was comprised of 54 HIV sero-negative, healthy participants. The
study participants from the previously conducted flow cytometry study was comprised of 48
subjects (44 male; 4 female) with a median age of 41 (range: 19–66) with the following racial
distribution: Caucasian (N = 14), African-American (N = 18), Hispanic (N = 8), unknown
(N = 8). The study participants of newly recruited CFAR CORE subjects for IHC comparisons
consisted of 5 sigmoid and 6 rectal, one rectal biopsy was not suitable for analysis, so it was ex-
cluded, this gave a total of 5 sigmoid and 5 rectal biopsies for analysis. These samples were col-
lected from 6 male subjects with a median age of 25 (range: 19–47) with the racial distribution
of: Caucasian (N = 2), 1 African-American (N = 1), Asian (N = 1), unknown (N = 1). There
were no discernable differences between these two small study populations.
Both sigmoid and rectal mucosa are densely populated with CD3+
lymphocytes
To establish an average size of mucosal biopsies, measurements of 20 biopsies from two per-
sons (10 from each anatomic site) were assessed, yielding a mean volume of 20.2 ± 5.9 mm3
(data not shown). By both manual and automated counting methods, CD3+ lymphocytes were
widely distributed throughout the epithelia, lamina propria and clustered in lymphoid aggre-
gates (Fig 1a–1d). Lymphoid aggregates were identified in ~60% sections from both sigmoid
and rectal mucosa samples; there were ~1.33 lymphoid aggregates/section (Fig 1c). The distri-
bution of CD45 was assessed in the same tissues and was found to also be widely distributed
similar to CD3+ T lymphocytes. CD45 is present on all differentiated hematopoietic cells, ex-
cept red blood cells and plasma cells, which include T lymphocytes, monocytes, and some den-
dritic cells (S2 Fig).
Manual counting revealed overall densities of 37,400 ± 2,801/mm3 and 33,700 ± 4,324/mm3
in sigmoid colonic and rectal mucosa, respectively (Fig 2c). Using an average diameter of 12 μm
for an activated T lymphocyte (corresponding to a volume of 905 μm3 per cell), these counts
suggest that ~3.38 ± 0.25% and ~3.05 ± 0.39% of the sigmoid and rectal mucosal tissue biopsy
volumes, respectively, are composed of T lymphocytes. Based on assumptions that mucosal
thickness (up to but not including muscular layers) to be 1.5mm with the sigmoid colon ~35cm
long with an inner diameter of 3.5cm (total mucosal volume of 350 x [π x 19.02 - π x 17.52] =
6020 mm3), and rectum to be 5cm in length [14] with an inner diameter of 5cm (total mucosal
volume of 50 x [π x 26.52 - π x 25.02] = 8494 mm3), these counts equate to 2.25 ± 0.17 x 109 and
4.09 ± 0.52 x 108 total T lymphocytes in the sigmoid and rectal mucosa respectively, or
2.66 ± 0.21 x 109 total for the entire rectosigmoid mucosa.
Automated counting protocol yields are similar to those from direct,
manual counting
To assess the validity of the membrane Leica algorithm automated counting protocol (Leica
Biosystems Technologies, Inc.), the same specimens manually counted above were re-analyzed
(Fig 2a–2c). After optimization, this protocol counted CD3+ cells with a high degree of correla-
tion to manual counting. Automated versus manual counting were compared for three
T Lymphocytes in Human Colorectal Mucosa
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representative fields each from sigmoid and rectal mucosal biopsies from five persons. The
best-fit line by linear regression yielded an overall r2 value of 0.90, with a slope of 1.04 and y-in-
tercept of 0 (Fig 2d). These data validated a rapid and highly reliable approach to automated
counting of cells after immunoperoxidase staining for these markers. Analysis of the epitheli-
um, lamina propria, and lymphoid aggregates as separate compartments yielded similar aver-
ages per mm3 of CD3+ cells (Fig 2e and 2f).
CD4+ and CD8+ T lymphocytes are similarily distributed in sigmoid and rectal mucosal
tissues. The localization and number of CD4+ and CD8+ subsets of T lymphocytes were
characterized in situ using IHC and manual counting. Both CD4+ and CD8+ T lymphocytes
were widely distributed in the lamina propria, (Fig 3a) and, as expected, more so in denser
areas of lymphoid aggregates (Fig 3b). CD8+ and some CD4+ T lymphocytes were additionally
located sparsely intraepithelially, in agreement with prior observations [7,15]. To confirm
CD4+ and CD8+ lymphocytes (and not macrophages and dendritic cells which also express
CD4+ and CD8+ receptors), we used immunofluorescence (IF) dual staining with CD3+
(Fig 3c) followed by manual counting of double positives CD3+CD4+ and CD3+CD8+ cells. In
the rectum, CD3+CD4+ T lymphocytes accounted for 57% of T lymphocytes (absolute num-
bers: 21,577 ± 332 cells/mm3); and 42% were CD3+CD8+ T lymphocytes (absolute numbers:
17,090 ± 275 cells/mm3). By volume, 1.95% (± 0.03%) and 1.55% (± 0.11%) of the rectal mu-
cosa is composed of CD4+ and CD8+ T lymphocytes, respectively. Similarly, in the sigmoid,
CD3+CD4+ T lymphocytes accounted for 57% CD3+CD4+ T lymphocytes (absolute number
21,300 ±1,476 cells/mm3) and 40% CD3+CD8+ (15,000 ± 275/mm3) T lymphocytes. This cor-
responds to 2.07 ± 0.13% and 1.37 ± 0.02% of the sigmoid colonic mucosa being composed of
CD4+ and CD8+ T lymphocytes respectively. Based on the assumed volumes for sigmoid and
rectal mucosae above, these figures suggested that they contain 1.38 ± 0.09 x 109 and
Fig 1. CD3+ lymphocytes are similar in normal human sigmoid colonic and rectal mucosa. Sigmoid
colonic and rectal mucosal sections immunostained for CD3. The membrane red/brown colors denote
positive staining (red/brown, AEC chromogen). Specimens were counterstained with hematoxylin. (A)Upper
panel original magnification 200x (B) lower panel 400x (C) lower magnification showing distribution of
lymphoid aggregates in both sigmoid and rectum (100x). Arrows represent lymphoid aggregates.
doi:10.1371/journal.pone.0122723.g001
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Fig 2. Application of an automated algorithm to quantitate T lymphocytes in immunostained sigmoid
colonic and rectal mucosa. Amembrane detection algorithm was applied to CD3-immunostained sigmoid
colonic and rectal mucosal biopsies from 5 healthy donors (5 sigmoid colon, 5 rectum). (A) Digital images with
AEC chromogen staining for CD3 and hematoxylin counterstaining. (B) Mark-up images with red, orange,
and yellow pixels depicting immunopositive cells (strong, moderate, and weak intensity, respectively), and
black pixels depicting nuclei for immunonegative cells. Bar = 100 μm. Arrowheads denote manual
enumeration. (C) Tissue concentrations of T lymphocytes obtained using both methods and analyzed by
paired t test. (D) Correlation between counts obtained by manual and automated enumeration of the same
regions. R2 value = 0.90 (E) Tissue concentrations of T lymphocytes in epidermis (Epi), lamina propria (Lp),
and lymphoid aggregates (La; when present) of sigmoid colon and rectum. (F) Average T lymphocyte
concentrations obtained from averaging the various compartments from the sigmoid colon and rectum.
doi:10.1371/journal.pone.0122723.g002
T Lymphocytes in Human Colorectal Mucosa
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2.62 ± 0.04 x 108 CD4+ T lymphocytes, and 9.10 ± 0.17 x 108 and 5.41 ± 0.38 x 108 CD8+ T
lymphocytes respectively. Efforts to adjust numbers of T lymphocytes subsets to biopsy vol-
ume, enables the reporting of the “# of cells/biopsy”. Consistent with our recent report, there
was a significant population of CD4+ but CD3- cells that co-expressed CD68 and CD1a indi-
cating they were of monocyte/macrophage lineage (data not shown) [9].
Flow cytometric counting of MMCmarkedly underestimates densities of CD4+ and
CD8+ T lymphocytes. Only sigmoid biopsies were used to compare differences in counted
yields “per biopsy” between IHC and flow cytometry with TruCount beads. Biopsy samples
were processed using standard methodology (with collagenase II digestion) to isolate MMC
from sigmoid colonic mucosa of healthy individuals. The flow cytometry yield of CD4+ and
CD8+ T lymphocytes in terms of number (versus percentage) was quantified to permit report-
ing “per biopsy” as was done by IHC methods. By flow, the sigmoid colonic mucosa yielded a
mean of 174,939± 13,229 CD3+ lymphocytes per biopsy (7,288 ± 551 cells per mm3). Of these,
63% were CD4+ T lymphocytes (4,549 ± 381) and 37% CD8+ T lymphocytes (2,708 ± 245 cells
per mm3) (Fig 3d). These yields (and SEM) are similar to previously reported yields by flow cy-
tometry. Compared to the densities of total CD3+ lymphocytes per biopsy in sigmoid colon bi-
opsies using IHC, flow cytometry yields were 79.3% lower. When compared to IHC-counted
CD4+ and CD8+ T lymphocyte subsets per biopsy, flow cytometry yields were approximately
77.6% and 81.9% lower respectively, (Fig 4).
Fig 3. Distribution and number of CD4+ and CD8+ T lymphocytes in sigmoidmucosal and rectal mucosa. (A) Immunoperoxidase for CD4 and CD8
with hematoxylin counterstaining. (B) Distribution of CD4+ and CD8+ cells in lymphoid aggregates. (C) Confocal microscopy of CD3+CD4+ and CD3+CD8+
subsets of T lymphocytes. Bar = 50μm. (D) Densities of CD4+ and CD8+ T lymphocytes compared to densities obtained from flow analysis. GL = gland;
Lu = lumen
doi:10.1371/journal.pone.0122723.g003
T Lymphocytes in Human Colorectal Mucosa
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Discussion
It is believed that the gastrointestinal tract and gut-associated lymphoid tissue (GALT) contain
the majority of total body lymphocytes [16]. The small intestine (~4–5 meters long; internal
Fig 4. Comparison of automated counts of in situ sigmoid colonic and rectal mucosal T lymphocytes versus isolation and flow cytometric
counting.Mucosal CD3+ T lymphocytes were isolated by mechanical tissue disruption and collagenase digestion. (A) Gating strategy for flow cytometric
analysis of isolated lymphocytes. (B) Comparison of the mean numbers of sigmoid colonic mucosal CD3+ lymphocytes isolated from 30 sigmoid biopsies
from similar persons versus automated (n = 48) and manual counting of 5 sigmoid biopsies and 5 rectal biopsies from 5 subjects. Dots represent the means
of 3–5 regions analyzed with bars representing standard error of the means. (Mann-Whitney Rank Sum test p<0.001).
doi:10.1371/journal.pone.0122723.g004
T Lymphocytes in Human Colorectal Mucosa
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diameter ~3 cm) has a mucosa more densely populated with immune cells than the colon in-
cluding more organized lymphoid structures (Peyer’s patches (PP)) while the colon (~5 feet in
length; internal diameter 5cm) has similarly diffuse lymphocytes (both intraepithelial lympho-
cytes (IEL) and lamina propria lymphocytes (LPL)) but lacks PP, instead having more loosely
organized lymphoid aggregates (LA). Different segments of the small (duodenum, jejunum,
ileum) and large (ascending, transverse, descending, sigmoid, rectum) bowel show regional
heterogeneity in the organization and density of these cells; these are factors that must be taken
into consideration in study design and hypothesis testing.
Using automated approaches we quantified T cells in situ, to determine their numbers and
distribution in biopsies from healthy distal colon and rectal mucosal compartments. Mucosal
compartments have been under increasing focus in the field of HIV prevention, and in inflam-
matory bowel diseases such as ulcerative colitis and Crohn’s disease.
Despite the common assumption that most human T lymphocytes reside in the gut, there
are surprisingly few data directly addressing this issue. We sought to define absolute numbers
and characterize locations of T lymphocytes in distal human colorectal mucosa by direct visu-
alization of mucosal tissue in situ using frozen sections and automated quantification tech-
niques. With this direct data, we derived estimates of the numbers of resident CD3+, CD4+ and
CD8+ T lymphocytes in the sigmoid as well as rectal mucosal compartments. Using these data
as our baseline gold standard, we demonstrate significant losses in yields of quantified T lym-
phocyte subsets using flow cytometry.
Overall, the direct counting identifies similar numbers of CD3+ lymphocytes in sigmoid
and rectal mucosal with similar ratios of subsets: ~21K CD4+ and ~15K CD8+ T lymphocytes
per mm3, respectively, in sigmoid mucosa and ~22K CD4+ and ~17K CD8+ T lymphocytes per
mm3, respectively, in rectal mucosa, There was no significant difference between subsets within
or between sigmoid/rectal mucosa.
Our first intention was to determine absolute numbers present in biopsies from healthy indi-
viduals to provide normative ranges for comparison in disease conditions. Having the absolute
numbers enables a more informed extrapolation of the total number of T lymphocytes in these
biopsies to the regional compartments. Second, by comparing direct and optimized automated
counting algorithms, confidence can now be derived when utilizing this much more efficient ap-
proach than the very time-consuming and technician-dependent direct quantifications.
Thirdly, these IHC quantifications ‘per biopsy’ permitted comparisons to yields via flow cy-
tometry ‘per biopsy’ (using TruCount beads). Importantly, for CD3+ as well as CD4+ and
CD8+ T lymphocyte subsets, it appears ~79% of these lymphocytes phenotypes are lost after bi-
opsy acquisition, MMC isolation, staining, fixation and flow cytometric analyses. No efforts
were made here to identify which steps might be accounting for the losses and one slight limita-
tion was the inability to obtain biopsies from a subject to freeze and manually count to use as a
direct comparison to flow cytometry isolation which would have controlled for person to per-
son variation. However, we did address this in a previous study were we describe results from
four isolations performed on the same donor at the same time to document inter subject varia-
tion in MMC phenotypes and we did not find any significant differences [10]. While flow cy-
tometry is useful for multiparametric analysis of cells in suspension [2], there is a trade-off not
only in the obvious loss of information about the relative anatomic relationships of different
cells, but also potentially a significant selection bias in extrapolating flow-derived results back
to resident-cell populations in tissues. As well, it has been demonstrated that conventional col-
lagenase and isolation methods disrupt and substantially reduce the expression of macrophage
markers and several T lymphocyte markers such as CD3, CD4, and CD8 [17–20]. We have pre-
viously shown that PBMCs put through the same protocol we use here to isolate MMCs does
T Lymphocytes in Human Colorectal Mucosa
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not demonstrate significantly different CD3/CD4/CD8 expression compared to the PBMC’s
stained prior to the 2–3 hour, collagenase and staining process [21].
Whether most of the total body human CD4+ T lymphocytes reside in the gut has been called
into question. This concept is mostly based on extrapolations from animal studies [7, 22–23],
and there are surprisingly few human data. In a review and editorial concerning the total body
distribution of CD4+ T lymphocytes, Ganusov and De Boer suggested that ~11% of CD4+ T
lymphocytes reside in the gut, including ~6.5% in the gut lamina propria [6]. However, this re-
port combined only estimates from prior reviews byWestermann and Pabst [5] on B lympho-
cyte and CD4+ and CD8+ T lymphocyte ratios in the small intestine and from Trepel [4] on
numbers of total lymphocytes in various tissue compartments (extrapolated from rats) [6].
More recently, Di Mascio et al proposed higher total body estimates CD4+ T lymphocytes but
similar gut percentages, based on using radiotracer-tagged anti-CD4 monoclonal antibodies in
macaques to directly quantify.
Here we report, using direct/automated counting, that the healthy human sigmoid and rec-
tal mucosa contain about 1.38 ± 0.09 x 109 and 2.62 ± 0.04 x 108 CD4+ T lymphocytes, or
about 1.6 x 109 total. Assuming these sections account for ~5% of the digestive tract [24] and
accounting for the greater density of lymphocytes in small bowel, these numbers fall within
range of more recently published estimates [7,14].
Immunohistochemical analysis of tissues, while currently limited in the number of simulta-
neous markers that can be assessed, remains the gold standard in terms of both anatomic/
physical representation but also absolute numbers. Recently, the analysis of IHC images has be-
come routinely semi-automated with the aid of image processing software [25–26]. This ap-
proach, much less operator-dependent, has been used with some success to study heterogeneous
populations of human tumors [27–29]. Although semi-automated analysis of IHC requires a
great degree of standardization and optimization initially, it can achieve a quantitative and reli-
able output of protein expression on cells in situ, as in quantifying HER2/ER receptors on breast
cancer cells in tumors [28–30]. Each specific application requires standardization of parameters
such as staining threshold, the size and roundness of the nuclei and cells, and potentially other
parameters such as cell elongation for each tissue and detection antibody [26].
Having accurate, clinically-relevant numbers of target cells in vulnerable but also immunolog-
ically-active compartments are essential for the evolving field of targeted therapies (including
vaccines, treatment, cure efforts) as well as more conventional compartment drug delivery fo-
cused on certain cell types. Both the absolute numbers quantified and awareness of the significant
losses of cells assessed by flow cytometry are important steps. While conducting these descriptive
but important comparisons would have been preferable using the same study subjects, this
would have been resource-intensive (both human and financial). Given the large number of sub-
ject’s flow cytometry results available and the intensity of the detailed IHC (manual and automat-
ed) counting, we felt this was a merited, leveraged, pilot investigation for CD3+, CD4+ and CD8+
T lymphocyte populations.
In summary, we find that healthy human colorectal mucosa is rich in T lymphocytes with
specific anatomic relationships of their CD4+ and CD8+ subsets, and provide solid estimates of
the densities and numbers of these cells. Additionally, we demonstrate that mucosal cell isola-
tion by current conventional techniques recovers a minority of the mucosal T lymphocytes
identified by flow cytometry after a standard tissue isolation protocol. Consequently, flow cyto-
metric analyses must be interpreted with caution and ideally complemented with IHC studies
of cells in situ. Accurate delineation of leukocytes in human mucosal tissues will be pivotal in
understanding mucosal immunity as it relates to the pathogenesis of infections and autoim-
mune diseases in this compartment, as well as the development of vaccines and therapeutics
applicable to mucosal immunity.
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Supporting Information
S1 Fig. Calculations for lymphocyte counts. Calculations based on the average diameter of a
T lymphocyte to determine amount of sections that will constitute a whole T lymphocyte in
rectal and colonic tissue.
(TIF)
S2 Fig. CD45 Bio-distribution in normal colorectal mucosal tissue. Sigmoid colonic and rec-
tal mucosal sections immunostained for CD45. The membrane red/brown colors denote posi-
tive staining (red/brown, AEC chromogen). Specimens were counterstained with hematoxylin.
(A) Magnification 200x (B) 400x.
(TIF)
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